By Euro Weekly News Media • 20 February 2023 • 6:11
Image - Is cancer inherited? Quironsalud Torrevieja
Cancers are predominantly genetic diseases, mostly due to the accumulation of mutations, which are also influenced by environmental and other factors, which in some cases may be the triggers.
A small proportion of these tumours are hereditary: “Hereditary cancers are the consequence of germline mutations in specific genes that increase susceptibility to cancer,” explains Dr Ramon Gonzalez Manzano, an oncologist at the Quironsalud Torrevieja Platform.
“This susceptibility is transmitted between family members according to different inheritance patterns. Susceptibility to cancer is inherited, which does not imply the certainty of developing it in all cases,” explains Dr Gonzalez.
The predisposition to inheriting cancer is due to the presence of mutations or other genetic alterations that alter the function of a gene that is critical for regulating biological processes related to the onset, development or progression of some types of cancer.
“The mutation can be inherited from parents or new-onset in a subject. Cancers of hereditary origin account for around 5% of all cancers that are diagnosed,” says Dr Gonzalez.
More than 160 genes related to hereditary predisposition to cancer are known.
When a genetic defect (i.e. pathological mutation) of one of these genes is inherited, the carrier of the altered gene has an increased risk of developing cancer, which is higher or lower depending on the gene in question.
Each of these genes related to hereditary predisposition to cancer can lead to one or more specific types of cancer in the carrier. For example, women with a mutation in the BRCA1 or BRCA2 gene may develop breast cancer at a younger age (usually before the age of 50) than breast cancers occurring in the general population. But other patients may develop ovarian cancer instead of breast cancer, or even both types of tumours in the same patient.
According to Dr Gonzalez, this is one of the questions frequently asked by patients diagnosed with any type of tumour: Will my relative have the same type of cancer as me? The answer is that “it depends on the inheritance pattern of the hereditary predisposition gene under consideration”.
The most common inheritance patterns are as follows. The most common is autosomal dominant. In the case of autosomal dominant inheritance (as with BRCA1 or BRCA2), there is a 50 per cent chance that a parent carrying a pathological mutation in one of these genes will pass it on to their offspring.
Other genes, such as those causing the rare disease “xeroderma pigmentosum”, which is characterised by an extreme sensitivity to ultraviolet radiation from sunlight that is associated with the development of skin cancers, follow an autosomal recessive inheritance, and in this case, the probability is 25 per cent, generally requiring both parents to be carriers. Furthermore, in these cases, half of the offspring are likely to be carriers of the genetic alteration even if they do not suffer from the disease.
It should be borne in mind that not all patients with pathological mutation in genes with a hereditary predisposition to cancer develop it.
According to the expert, there are some warning signs that should alert us to the possible presence of a genetic alteration in genes with a hereditary predisposition to cancer:
– The appearance of tumours at a very early age. – Presence of bilateral tumours in the case of double organs (e.g. breasts, kidneys, etc.) or several synchronous tumours. – Presence of multiple cases of cancer in a family.
In these eventualities, a specialist in cancer genetics should be consulted, who will indicate the relevant genetic tests to detect the genetic alterations that cause a hereditary predisposition to cancer.
The diagnosis is mostly indicated in the person affected by cancer by means of a genetic test.
This type of study simply requires a blood or buccal mucosa sample.
From these samples, DNA is extracted for sequencing. The most common technique currently used for genetic studies of DNA sequences is next-generation sequencing using ultra-sequencing, a technique that allows simultaneous sequencing of multiple genes.
The current trend is to use multi-gene panels, confirming the presence of any positive findings with conventional DNA sequencing.
Thank you for taking the time to read this article. Do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories. Remember, you can also follow us on Facebook and Instagram.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Download our media pack in either English or Spanish.